Latest news
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMTCBAK Energy to Showcase AI Data Center Backup Power Strategy and Global Capacity Roadmap at the Clean Energy Metals Virtual Investor Conference on August 27, 2026 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:48 GMTSchouw & Co. share buy-back programme, week 32 2026 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:47 GMTBaird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:41 GMTRush Street Interactive to Participate at the Oppenheimer 29th Annual Technology, Internet & Communications Conference - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:40 GMTCapricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13 - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:32 GMTAutonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:11 GMTAIM Completes Pancreatic Cancer Study Dosing; Phase 3 Planned - Stock TitanStock Titan · Mon, 10 Aug 2026 12:36:00 GMT